Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€529.00
18.12.23
€558.00
18.12.24
6.62%
06.01.24

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Exact Sciences

Start price
Target price
Perf. (%)
€62.80
20.04.23
€65.50
03.05.24
9.71%
27.12.23

buy
MicroVision Inc

Start price
Target price
Perf. (%)
€2.44
02.12.23
€2.00
02.12.24
-1.29%
05.12.23

Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
MicroVision Inc

Start price
Target price
Perf. (%)
€2.36
29.11.23
€2.00
29.11.24
3.49%
02.12.23

Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
MicroVision Inc

Start price
Target price
Perf. (%)
€2.23
23.11.23
€2.00
23.11.24
5.92%
29.11.23

Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€246.80
19.09.23
€250.00
19.09.24
4.13%
27.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€502.50
17.08.23
€510.00
17.08.24
10.75%
13.09.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€152.60
24.07.23
€155.00
24.07.24
3.47%
16.08.23

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
buy
Reata Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€90.50
28.06.23
€120.00
31.01.26
64.64%
30.07.23

Could be very worthwhile Investment >20% year
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€60.00
08.09.22
€80.00
31.12.24
35.00%
24.06.23

Could be very worthwhile Investment >20% year
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€388.00
05.05.23
€395.00
05.05.24
3.52%
12.05.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Seagen Inc.

Start price
Target price
Perf. (%)
€165.90
15.08.22
€180.00
31.01.24
9.64%
08.05.23

Could be very worthwhile Investment >20% year
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€16.10
07.05.22
€20.00
07.05.23
222.26%
08.05.23

Could be very worthwhile Investment >20% year
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.50
03.01.23
€30.00
31.12.25
76.00%
05.05.23

Could be very worthwhile Investment >20% year
buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€16.97
06.02.23
€27.00
31.12.25
87.64%
05.05.23

Could be very worthwhile Investment >20% year
buy
Immunogen Inc.

Start price
Target price
Perf. (%)
€3.98
09.01.23
€8.00
31.12.25
178.89%
05.05.23

Could be very worthwhile Investment >20% year
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€6.10
19.12.22
€18.00
31.12.24
226.15%
05.05.23

Could be very worthwhile Investment >20% year
buy
Madrigal Pharmaceuticals inc.

Start price
Target price
Perf. (%)
€66.50
30.09.22
€120.00
31.12.24
324.36%
05.05.23

Could be very worthwhile Investment >20% year
buy
Reata Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€47.20
07.02.23
€50.00
07.02.25
100.21%
05.05.23

Could be very worthwhile Investment >20% year
buy
IVERIC bio Inc.

Start price
Target price
Perf. (%)
€17.23
29.09.22
€26.00
31.12.24
98.47%
05.05.23

Could be very worthwhile Investment >20% year
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€233.45
25.04.22
€250.00
25.04.23
14.61%
26.04.23

Could be worthwhile Investment >10% per year
Fair valuation
Some uniques
Higher risks for its business
buy
Seagen Inc.

Start price
Target price
Perf. (%)
€152.08
07.09.22
€180.00
31.12.24
21.00%
21.03.23

Could be very worthwhile Investment >20% year
buy
Meridian Bioscience Inc.

Start price
Target price
Perf. (%)
€19.00
28.01.22
€20.00
28.01.23
62.63%
29.01.23

Could be worthwhile Investment >10% per year
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€407.05
24.01.22
€418.00
24.01.23
10.66%
25.01.23

Could be worthwhile Investment >10% per year
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€32.60
28.12.22
€40.00
28.12.23
50.15%
02.01.23